As of May 22
| -0.005 / -0.76%|
The 2 analysts offering 12-month price forecasts for OHR Pharmaceutical Inc have a median target of 7.50, with a high estimate of 10.00 and a low estimate of 5.00. The median estimate represents a +1,053.85% increase from the last price of 0.65.
The current consensus among 2 polled investment analysts is to Buy stock in OHR Pharmaceutical Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.